Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host immune system and injured tissue microenvironment refer to the complex, dynamic ecosystem of cells, signaling molecules, and physical factors present at the site of tissue damage or disease. This environment is composed of resident and recruited immune cells (such as macrophages, neutrophils, and T-cells), fibroblasts, endothelial cells, and the extracellular matrix, all interacting within a landscape often characterized by hypoxia, acidosis, and high metabolic demand (Source: Nature Reviews Immunology, 2018). Its primary biological function is to detect damage-associated molecular patterns (DAMPs), initiate an inflammatory response to clear pathogens or debris, and subsequently transition into a proliferative and remodeling phase to restore tissue integrity (Source: Science, 2017). In many disease states, this microenvironment becomes dysregulated; for example, in chronic wounds or fibrosis, the transition from inflammation to repair is stalled, while in cancer, the 'tumor microenvironment' is hijacked to suppress immune surveillance and promote malignancy (Source: New England Journal of Medicine, 2008). Therapeutic intervention does not usually target the 'environment' as a single molecule but rather focuses on specific components—such as neutralizing pro-inflammatory cytokines like TNF-α or using checkpoint inhibitors to reinvigorate exhausted T-cells within the milieu (Source: Nature Medicine, 2018). Because this is a systemic and multi-component physiological context rather than a single protein or receptor, it is classified as a system-level target rather than a discrete molecular target.
Drugs targeting this system typically act by modulating cellular recruitment, inhibiting specific cytokine signaling pathways, or altering the physical and chemical properties of the extracellular matrix to promote healing or suppress pathological inflammation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host immune system and injured tissue microenvironment.